Activation of angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis attenuates the cardiac reactivity to acute emotional stress

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 305, Issue 7, 2013, Pages

  Martins Lima, Augusto ^a   Xavier, Carlos Henrique ^a,d   Ferreira, Anderson José ^a   Raizada, Mohan K ^b   Wallukat, Gerd ^c   Velloso, Elizabeth Portugal Pimenta ^a   dos Santos, Robson Augusto Sousa ^a   Fontes, Marco Antônio Peliky ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UNIVERSITY OF FLORIDA   (United States)

^c MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^d FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

Author keywords

Angiotensin; Cardiovascular; Stress

Indexed keywords

1 [( 2 DIMETHYLAMINO)ETHYLAMINO] 4 (HYDROXYMETHYL) 7 [( 4 METHYLPHENYL)SULFONYLOXY] 9H XANTHENE 9 ONE; ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN RECEPTOR; ANGIOTENSIN[1-7]; ANGIOTENSIN[1-7][7 DEXTRO ALANINE]; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ISOPRENALINE; MAS RECEPTOR; SODIUM CHLORIDE; UNCLASSIFIED DRUG; URETHAN;

ACUTE STRESS; AIR; AIR JET; ANESTHESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; ATTENUATION; CARDIOVASCULAR RESPONSE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DORSOMEDIAL HYPOTHALAMIC NUCLEUS; DRUG EFFICACY; EMOTIONAL STRESS; EVOKED RESPONSE; HEART BEAT; HEART MUSCLE CELL; HEART RATE; INCUBATION TIME; KIDNEY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RENAL SYMPATHETIC NERVE ACTIVITY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYMPATHETIC NERVE; TACHYCARDIA;

ANGIOTENSIN; CARDIOVASCULAR; STRESS;

ADRENERGIC BETA-AGONISTS; ANGIOTENSIN I; ANIMALS; ARTERIAL PRESSURE; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ENZYME ACTIVATORS; HEART RATE; HEMODYNAMICS; HYPOTHALAMUS; INJECTIONS, INTRAVENOUS; INJECTIONS, INTRAVENTRICULAR; MALE; MYOCYTES, CARDIAC; PEPTIDE FRAGMENTS; PEPTIDYL-DIPEPTIDASE A; PROTO-ONCOGENE PROTEINS; RATS; RATS, WISTAR; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; STRESS, PSYCHOLOGICAL; SYMPATHETIC NERVOUS SYSTEM; TACHYCARDIA;

EID: 84884927395     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00433.2013     Document Type: Article

References (75)

1. Ahima RS, Patel HR, Takahashi N, Qi Y, Hileman SM, Zasloff MA. Appetite suppression and weight reduction by a centrally active aminosterol. Diabetes 51: 2099-2104, 2002.
2. Arnold AC, Sakima A, Kasper SO, Vinsant S, Garcia-Espinosa MA, Diz DI. The brain renin-angiotensin system and cardiovascular responses to stress: insights from transgenic rats with low brain angiotensinogen. J Appl Physiol 113: 1929-1936, 2012.
3. Bader M, Santos RA, Unger T, Steckelings UM. New therapeutic pathways in the RAS. JRAAS 13: 505-508, 2012.
4. Bandler R, Keay KA, Floyd N, Price J. Central circuits mediating patterned autonomic activity during active vs. passive emotional coping. Brain Res Bull 53: 95-104, 2000.
5. Becker LK, Etelvino GM, Walther T, Santos RA, Campagnole-Santos MJ. Immunofluorescence localization of the receptor Mas in cardiovascular-related areas of the rat brain. Am J Physiol Heart Circ Physiol 293: H1416-H1424, 2007.
6. Benter IF, Ferrario CM, Morris M, Diz DI. Antihypertensive actions of angiotensin-(1-7) in spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 269: H313-H319, 1995.
7. Bild W, Ciobica A. Angiotensin-(1-7) central administration induces anxiolytic-like effects in elevated plus maze and decreased oxidative stress in the amygdala. J Affect Disord 145: 165-171, 2013.
8. Block CH, Santos RA, Brosnihan KB, Ferrario CM. Immunocytochemical localization of angiotensin-(1-7) in the rat forebrain. Peptides 9: 1395-1401, 1988.
9. Braga AN, da Silva Lemos M, da Silva JR, Fontes WR, dos Santos RA. Effects of angiotensins on day-night fluctuations and stress-induced changes in blood pressure. Am J Physiol Regul Integr Comp Physiol 282: R1663-R1671, 2002.
10. Buccafusco JJ, Serra M. Role of cholinergic neurons in the cardiovascular responses evoked by central injection of bradykinin or angiotensin II in conscious rats. Eur J Pharmacol 113: 43-51, 1985.
11. Byku M, Macarthur H, Westfall TC. Inhibitory effects of angiotensin-(1-7) on the nerve stimulation-induced release of norepinephrine and neuropeptide Y from the mesenteric arterial bed. Am J Physiol Heart Circ Physiol 298: H457-H465, 2010.
12. Campagnole-Santos MJ, Heringer SB, Batista EN, Khosla MC, Santos RA. Differential baroreceptor reflex modulation by centrally infused angiotensin peptides. Am J Physiol Regul Integr Comp Physiol 263: R89-R94, 1992.
13. Cao WH, Fan W, Morrison SF. Medullary pathways mediating specific sympathetic responses to activation of dorsomedial hypothalamus. Neuroscience 126: 229-240, 2004.
14. Chaves GZ, Caligiorne SM, Santos RA, Khosla MC, Campagnole-Santos MJ. Modulation of the baroreflex control of heart rate by angiotensin-(1-7) at the nucleus tractus solitarii of normotensive and spontaneously hypertensive rats. J Hypertens 18: 1841-1848, 2000.
15. Chen D, La Greca L, Head GA, Walther T, Mayorov DN. Blood pressure reactivity to emotional stress is reduced in AT1A-receptor knockout mice on normal, but not high salt intake. Hypertens Res 32: 559-564, 2009.
16. Dampney RA, Tagawa T, Horiuchi J, Potts PD, Fontes M, Polson JW. What drives the tonic activity of presympathetic neurons in the rostral ventrolateral medulla? Clin Exper Pharmacol Physiol 27: 1049-1053, 2000.
17. Davern PJ, Chen D, Head GA, Chavez CA, Walther T, Mayorov DN. Role of angiotensin II Type 1A receptors in cardiovascular reactivity and neuronal activation after aversive stress in mice. Hypertension 54: 1262-1268, 2009.
18. Drawnel FM, Wachten D, Molkentin JD, Maillet M, Aronsen JM, Swift F, Sjaastad I, Liu N, Catalucci D, Mikoshiba K, Hisatsune C, Okkenhaug H, Andrews SR, Bootman MD, Roderick HL. Mutual antagonism between IP(3)RII and miRNA-133a regulates calcium signals and cardiac hypertrophy. J Cell Biol 199: 783-798, 2012.
19. Felix D, Khosla MC, Barnes KL, Imboden H, Montani B, Ferrario CM. Neurophysiological responses to angiotensin-(1-7). Hypertension 17: 1111-1114, 1991.
20. Feng Y, Xia H, Cai Y, Halabi CM, Becker LK, Santos RA, Speth RC, Sigmund CD, Lazartigues E. Brain-selective overexpression of human angiotensin-converting enzyme type 2 attenuates neurogenic hypertension. Circ Res 106: 373-382, 2010.
21. Ferrario CM. Angiotensin-converting enzyme 2 and angiotensin-(1-7): an evolving story in cardiovascular regulation. Hypertension 47: 515-521, 2006.
22. Ferreira AJ, Santos RA, Bradford CN, Mecca AP, Sumners C, Katovich MJ, Raizada MK. Therapeutic implications of the vasoprotective axis of the renin-angiotensin system in cardiovascular diseases. Hypertension 55: 207-213, 2010.
23. Fontes MA, Silva LC, Campagnole-Santos MJ, Khosla MC, Guertzenstein PG, Santos RA. Evidence that angiotensin-(1-7) plays a role in the central control of blood pressure at the ventro-lateral medulla acting through specific receptors. Brain Res 665: 175-180, 1994.
24. Fontes MA, Tagawa T, Polson JW, Cavanagh SJ, Dampney RA. Descending pathways mediating cardiovascular response from dorsomedial hypothalamic nucleus. Am J Physiol Heart Circ Physiol 280: H2891-H2901, 2001.
25. Fontes MA, Xavier CH, de Menezes RC, Dimicco JA. The dorsomedial hypothalamus and the central pathways involved in the cardiovascular response to emotional stress. Neuroscience 184: 64-74, 2011.
26. Gard PR, Haigh SJ, Cambursano PT, Warrington CA. Strain differences in the anxiolytic effects of losartan in the mouse. Pharmacol Biochem Behav 69: 35-40, 2001.
27. Gard PR, Mandy A, Sutcliffe MA. Evidence of a possible role of altered angiotensin function in the treatment, but not etiology, of depression. Biol Psych 45: 1030-1034, 1999.
28. Gomes da Silva AQ, Xavier CH, Campagnole-Santos MJ, Caligiorne SM, Baltatu OC, Bader M, Santos RA, Fontes MA. Cardiovascular responses evoked by activation or blockade of GABA(A) receptors in the hypothalamic PVN are attenuated in transgenic rats with low brain angiotensinogen. Brain Res 1448: 101-110, 2012.
29. Gonzaga C, Oscar GdCL, Martins Lima A, Xavier C, Santos & Fontes MAP R. Angiotensin-(1-7) in the basolateral amygdala but not in the dorsomedial hypothalamus attenuates the cardiovascular response evoked by acute stress. FASEB J 25: 843-813, 2011.
30. Grisk O, Dibona GF. Influence of arterial baroreceptors and intracerebroventricular guanabenz on synchronized renal nerve activity. Acta Physiol Scand 163: 209-218, 1998.
31. Grobe JL, Xu D, Sigmund CD. An intracellular renin-angiotensin system in neurons: fact, hypothesis, or fantasy. Physiology (Bethesda) 23: 187-193, 2008.
32. Guimaraes PS, Santiago NM, Xavier CH, Velloso EP, Fontes MA, Santos RA, Campagnole-Santos MJ. Chronic infusion of angiotensin-(1-7) into the lateral ventricle of the brain attenuates hypertension in DOCA-salt rats. Am J Physiol Heart Circ Physiol 303: H393-H400, 2012.
33. Hernandez Prada JA, Ferreira AJ, Katovich MJ, Shenoy V, Qi Y, Santos RA, Castellano RK, Lampkins AJ, Gubala V, Ostrov DA, Raizada MK. Structure-based identification of small-molecule angiotensin-converting enzyme 2 activators as novel antihypertensive agents. Hypertension 51: 1312-1317, 2008.
34. Holy Z, Braszko J, Kupryszewski G, Witczuk B, Wisniewski K. Angiotensin II-derived peptides devoid of phenylalanine in position 8 have full psychotropic activity of the parent hormone. J Physiol Pharmacol 43: 183-192, 1992.
35. Kar S, Gao L, Belatti DA, Curry PL, Zucker IH. Central angiotensin (1-7) enhances baroreflex gain in conscious rabbits with heart failure. Hypertension 58: 627-634, 2011.
36. Kawabe H, Lopes OU, Brosnihan KB, Saruta T, Ferrario CM. Angiotensin II pressor activity depends on medial and lateral anterior hypothalamic pathways. Angiology 46: 641-648, 1995.
37. Kenney MJ, Bealer SL. Arterial baroreceptors and brain histamine contribute to bradycardia to peripheral hyperosmolality. Am J Physiol Heart Circ Physiol 265: H1149-H1154, 1993.
38. LeDoux J. The amygdala. Current Biol 17: R868-R874, 2007.
39. Li P, Sun HJ, Cui BP, Zhou YB, Han Y. Angiotensin-(1-7) in the rostral ventrolateral medulla modulates enhanced cardiac sympathetic afferent reflex and sympathetic activation in renovascular hypertensive rats. Hypertension 61: 820-827, 2013.
40. Lisa M, Filippelli A, Marmo E, Wible JH Jr, DiMicco JA. Microinjection of muscimol into posterior hypothalamus blocks cardiovascular response to experimental stress in rats. Pharmacol Res 21, Suppl 1: 9-10, 1989.
41. Liu E, Xu Z, Li J, Yang S, Yang W, Li G. Enalapril, irbesartan, and angiotensin-(1-7) prevent atrial tachycardia-induced ionic remodeling. Int J Cardiol 146: 364-370, 2011.
42. Martin P, Massol J, Puech AJ. Captopril as an antidepressant? Effects on the learned helplessness paradigm in rats. Biol Psychiatry 27: 968-974, 1990.
43. Martins Lima AXC, Ferreira AJ, Santos Ras, Fontes MAP. Angiotensin-(1-7) reduces β-adrenergic mediated tachycardia. Hypertension 56: e50-e166, 2010.
44. Martins Lima AXC, Santos RAS, Fontes MAP. Central administration of angiotensin-(1-7) markedly reduces the tachycardia evoked by acute psychological stress exposure. FASEB J 23: 609-605, 2009.
45. Martins Lima AXC, Santos RAS, Raizada MK, Ferreira AJ, Fontes MAP. Central activation of the ACE2-Ang-(1-7)-Mas axis markedly reduces the tachycardia evoked by acute stress exposure. Hypertension 54: e26-e127, 2009.
46. Martins Lima AXC, Santos RAS, Raizada MK, Ferreira AJ, Fontes MAP. Peripheral activation of ACE2-Ang-(1-7)-Mas axis reduces the cardiovascular reactivity to acute stress in rats. FASEB J 24: 625-626, 2010.
47. Metzger R, Bader M, Ludwig T, Berberich C, Bunnemann B, Ganten D. Expression of the mouse and rat mas proto-oncogene in the brain and peripheral tissues. FEBS Lett 357: 27-32, 1995.
48. Muller-Ribeiro FC, Coimbra CC, Rodrigues-Machado Mda G, Fontes MA. Evidence that central action of paraquat interferes in the dipsogenic effect of Ang II. Neurotoxicology 31: 305-309, 2010.
49. Nicoletta P, Pochiero M, Losi E, Caputi AP. Interaction between renin-angiotensin system and cholinergic system in brain. Neuropharmacology 22: 1269-1275, 1983.
50. Pacak K, Palkovits M. Stressor specificity of central neuroendocrine responses: implications for stress-related disorders. Endocr Rev 22: 502-548, 2001.
51. Park JJ, Baum MJ. Intracerebroventricular infusion of the galanin antagonist M40 attenuates heterosexual partner preference in ferrets. Behav Neurosci 113: 391-400, 1999.
52. Pavel J, Benicky J, Murakami Y, Sanchez-Lemus E, Saavedra JM. Peripherally administered angiotensin II AT1 receptor antagonists are anti-stress compounds in vivo. Ann NY Acad Sci 1148: 360-366, 2008.
53. Paxinos GWC. The Rat Brain Stereotaxic Coordinates (2nd ed.). New York: Academic, 1986.
54. Pesquero JB, Fior-Chadi DR, Yu YG, Merjan AJ, Lindsey CJ, Paiva AC. Systemic site of action for pressor effect of angiotensin II injected into the fourth cerebral ventricle of rats? Can J Physiol Pharmacol 80: 431-439, 2002.
55. Rosendorff C, Lowe RD, Lavery H, Cranston WI. Cardiovascular effects of angiotensin mediated by the central nervous system of the rabbit. Cardiovasc Res 4: 36-43, 1970.
56. Saavedra JM, Armando I, Bregonzio C, Juorio A, Macova M, Pavel J, Sanchez-Lemus E. A centrally acting, anxiolytic angiotensin II AT1 receptor antagonist prevents the isolation stress-induced decrease in cortical CRF1 receptor and benzodiazepine binding. Neuropsychopharmacology 31: 1123-1134, 2006.
57. Samuels BC, Zaretsky DV, DiMicco JA. Dorsomedial hypothalamic sites where disinhibition evokes tachycardia correlate with location of raphe-projecting neurons. Am J Physiol Regul Integr Comp Physiol 287: R472-R478, 2004.
58. Santos RA, Campagnole-Santos MJ, Baracho NC, Fontes MA, Silva LC, Neves LA, Oliveira DR, Caligiorne SM, Rodrigues AR, Gropen Junior C, Carvalho WS, Simoes E, Silva AC, Khosla MC. Characterization of a new angiotensin antagonist selective for angiotensin-(1-7): evidence that the actions of angiotensin-(1-7) are mediated by specific angiotensin receptors. Brain Res Bull 35: 293-298, 1994.
59. Santos RA, Ferreira AJ, Pinheiro SV, Sampaio WO, Touyz R, Campagnole-Santos MJ. Angiotensin-(1-7) and its receptor as a potential targets for new cardiovascular drugs. Expert Opin Invest Drugs 14: 1019-1031, 2005.
60. Santos RA, Ferreira AJ, Simoes ESAC. Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis. Exp Physiol 93: 519-527, 2008.
61. Santos RA, Simoes e Silva AC, Maric C, Silva DM, Machado RP, de Buhr I, Heringer-Walther S, Pinheiro SV, Lopes MT, Bader M, Mendes EP, Lemos VS, Campagnole-Santos MJ, Schultheiss HP, Speth R, Walther T. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci USA 100: 8258-8263, 2003.
62. Silva AQ, Santos RA, Fontes MA. Blockade of endogenous angiotensin-(1-7) in the hypothalamic paraventricular nucleus reduces renal sympathetic tone. Hypertension 46: 341-348, 2005.
63. Sunter D, Hewson AK, Lynam S, Dickson SL. Intracerebroventricular injection of neuropeptide FF, an opioid modulating neuropeptide, acutely reduces food intake and stimulates water intake in the rat. Neurosci Lett 313: 145-148, 2001.
64. Tanaka M, McAllen RM. Functional topography of the dorsomedial hypothalamus. Am J Physiol Regul Integr Comp Physiol 294: R477-R486, 2008.
65. Von Bohlen und Halbach O, Walther T, Bader M, Albrecht D. Interaction between Mas and the angiotensin AT1 receptor in the amygdala. J Neurophysiol 83: 2012-2021, 2000.
66. Wallukat G, Wollenberger A. Effects of the serum gamma globulin fraction of patients with allergic asthma and dilated cardiomyopathy on chronotropic beta adrenoceptor function in cultured neonatal rat heart myocytes. Biomed Biochim Acta 46: S634-S639, 1987.
67. Walther T, Balschun D, Voigt JP, Fink H, Zuschratter W, Birchmeier C, Ganten D, Bader M. Sustained long term potentiation and anxiety in mice lacking the Mas protooncogene. J Biol Chem 273: 11867-11873, 1998.
68. Whalen EJ, Lewis SJ. In vivo evidence that isoproterenol may increase heart rate in the rat by mechanisms in addition to activation of cardiac beta(1)-or beta(2)-adrenoceptors. Eur J Pharmacol 382: 207-210, 1999.
69. Xavier CH, Nalivaiko E, Beig MI, Menezes GB, Cara DC, Campagnole-Santos MJ, Fontes MA. Functional asymmetry in the descending cardiovascular pathways from dorsomedial hypothalamic nucleus. Neuroscience 164: 1360-1368, 2009.
70. Xiao L, Gao L, Lazartigues E, Zucker IH. Brain-selective overexpression of angiotensin-converting enzyme 2 attenuates sympathetic nerve activity and enhances baroreflex function in chronic heart failure. Hypertension 58: 1057-1065, 2011.
71. Xing J, Kong J, Lu J, Li J. Angiotensin-(1-7) inhibits neuronal activity of dorsolateral periaqueductal gray via a nitric oxide pathway. Neurosci Lett 522: 156-161, 2012.
72. Yamazato M, Yamazato Y, Sun C, Diez-Freire C, Raizada MK. Overexpression of angiotensin-converting enzyme 2 in the rostral ventrolateral medulla causes long-term decrease in blood pressure in the spontaneously hypertensive rats. Hypertension 49: 926-931, 2007.
73. Yang RF, Yin JX, Li YL, Zimmerman MC, Schultz HD. Angiotensin-(1-7) increases neuronal potassium current via a nitric oxide-dependent mechanism. Am J Physiol Cell Physiol 300: C58-C64, 2011.
74. Zheng H, Liu X, Patel KP. Angiotensin-converting enzyme 2 overexpression improves central nitric oxide-mediated sympathetic outflow in chronic heart failure. Am J Physiol Heart Circ Physiol 301: H2402-H2412, 2011.
75. Zimmerman MC, Lazartigues E, Sharma RV, Davisson RL. Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system. Circ Res 95: 210-216, 2004.